Middle East and Africa Musculoskeletal Diseases Market Size

The Middle East and Africa musculoskeletal diseases market was valued at USD 0.30 billion in 2025, is estimated to reach USD 0.31 billion in 2026, and is projected to reach USD 0.44 billion by 2034, growing at a CAGR of 4.43% from 2026 to 2034.

MARKET OVERVIEW

Rising Incidence of Musculoskeletal Disorders with Aging Population

Musculoskeletal diseases are injuries/pain in the human musculoskeletal system, which also includes the joints, muscles, nerves, tendons, ligaments, and structures that support limbs, neck, and back. These are caused by sudden exertion, or they can arise from making the same motions repeatedly. With increasing age the risk of musculoskeletal diseases increases. Also, obese people havea high risk of musculoskeletal diseases.

Growing Prevalence of Musculoskeletal Disorders and Rising Demand for Bone-related Drugs

The significant drivers are an increase in prevalence of musculoskeletal disorders. Factors like unmet medical needs in developing nations and growing need of drugs related to bones will boost this industry.

REPORT COVERAGE

REPORT METRIC	DETAILS
Market Size Available	2025 to 2034
Base Year	2025
Forecast Period	2026 to 2034
Segments Covered	By Type, Type of Molecules, and Region.
Various Analyses Covered	Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities
Countries Covered	Brazil, Mexico, Argentina, Chile, Rest of Latin America
Market Leaders Profiled	AbGenomics International, AB Sciences, Ablynx, Akron Molecules, Johnson & Johnson, F. Hoffmann-La Roche, Pfizer, Eli Lilly, Adheron, Alder BioPharmaceuticals, Bioiberica, Bone Therapeutics, Edding Pharm, Boehringer Ingelheim, Can-Fite BioPharma, Celltrion, Celgene Corp., Cellular Biomedicine, ChemoCentryx, Cerapedics, Eupraxia Pharmaceuticals, and GlaxoSmithKline.

KEY MARKET PLAYERS

AbGenomics International, AB Sciences, Ablynx, Akron Molecules, Johnson & Johnson, F. Hoffmann-La Roche, Pfizer, Eli Lilly, Adheron, Alder BioPharmaceuticals, Bioiberica, Bone Therapeutics, Edding Pharm, Boehringer Ingelheim, Can-Fite BioPharma, Celltrion, Celgene Corp., Cellular Biomedicine, ChemoCentryx, Cerapedics, Eupraxia Pharmaceuticals, and GlaxoSmithKline are some of the key players in the Middle East and Africa Musculoskeletal Diseases market.

MARKET SEGMENTATION

This research report has been segmented and sub-segmented into the following categories:

By Type

Rheumatoid Arthritis
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others

By Type of Molecules

Biologics
Small Molecules

By Country

KSA
UAE
Israel
rest of GCC countries
South Africa
Ethiopia
Kenya
Egypt
Sudan
rest of Middle East and Africa

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Middle East and Africa Musculoskeletal Diseases Market